News

FATE

Small-Cap Biotechs Making the Rebound Before the Market

The Life Sciences Report | Equities.com |

Is this group ready to reverse course?


Investing in the New Era of Biotech

The Life Sciences Report | Equities.com |

Reni Benjamin of Raymond James has watched biotechnology move into a new era in which cells and genes can be manipulated to produce true disease-modifying results. In this interview with The Life


IPO Report: Fate Therapeutics (FATE)

Francis Gaskins | Equities.com |

Fate Therapeutics ($FATE) is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat orphan diseases, including


Blockchain in Healthcare - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Digital Health - How Blockchain technology can make health care systems more patient-centric and sustainable


Events

Sohn Investment Conference

Wall Street’s best and brightest investors participate in this unique, “must attend” event to share their expertise with an audience of more than 3,000 people, comprised of portfolio managers, asset…

Learn more